CD274 and cancer: The elucidation of these mechanisms has contributed to the implementation of the chemoimmunotherapy strategy, where chemotherapy results in the presentation of neoantigens on cancer cells, making them more visible to the immune system recognizing them by blocking the PD1/PD-L1 or CTLA4/B.7 pathways.